Delta-Fly Pharma, Inc.
Develops innovative, gentle anticancer agents with reduced side effects for cancer patients.
4598 | T
Overview
Corporate Details
- ISIN(s):
- JP3549370009
- LEI:
- Country:
- Japan
- Address:
- 徳島市川内町宮島錦野３７番地の５
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Delta-Fly Pharma, Inc. is a biopharmaceutical company specializing in the research and development of anticancer agents. The company utilizes its proprietary "Module Drug Development" concept to create innovative and "gentle" cancer treatments designed to have reduced side effects and be available at a reasonable price. Its development pipeline focuses on small molecule and RNA therapeutics for various cancers, including Acute Myeloid Leukemia. Delta-Fly Pharma's mission is to develop medicines that benefit cancer patients and society through its unique drug discovery approach.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-14 07:39 |
Interim Report
確認書
|
Japanese | 8.9 KB | ||
| 2025-11-14 07:35 |
Interim Report
半期報告書－第16期(2025/04/01－2026/03/31)
|
Japanese | 206.9 KB | ||
| 2025-06-27 08:44 |
Post-Annual General Meeting Information
臨時報告書
|
Japanese | 24.4 KB | ||
| 2025-06-27 08:39 |
Governance Information
内部統制報告書－第15期(2024/04/01－2025/03/31)
|
Japanese | 23.0 KB | ||
| 2025-06-27 08:34 |
Registration Form
確認書
|
Japanese | 8.8 KB | ||
| 2025-06-27 08:30 |
Registration Form
有価証券報告書－第15期(2024/04/01－2025/03/31)
|
Japanese | 1.1 MB | ||
| 2025-04-14 08:30 |
Prospectus
有価証券届出書（組込方式）
|
Japanese | 289.0 KB | ||
| 2024-11-14 07:39 |
Interim Report
確認書
|
Japanese | 8.9 KB | ||
| 2024-11-14 07:36 |
Interim Report
半期報告書－第15期(2024/04/01－2025/03/31)
|
Japanese | 180.2 KB | ||
| 2024-10-07 08:00 |
Major Shareholding Notification
臨時報告書
|
Japanese | 22.6 KB | ||
| 2024-09-20 08:00 |
Registration Form
有価証券届出書（組込方式）
|
Japanese | 326.2 KB | ||
| 2024-09-11 08:00 |
Major Shareholding Notification
臨時報告書
|
Japanese | 22.8 KB | ||
| 2024-06-28 08:31 |
Post-Annual General Meeting Information
臨時報告書
|
Japanese | 23.5 KB | ||
| 2024-06-28 08:28 |
Registration Form
確認書
|
Japanese | 8.8 KB | ||
| 2024-06-28 08:25 |
Governance Information
内部統制報告書－第14期(2023/04/01－2024/03/31)
|
Japanese | 22.6 KB |
Automate Your Workflow. Get a real-time feed of all Delta-Fly Pharma, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Delta-Fly Pharma, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Delta-Fly Pharma, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
%20Co.%2C%20Ltd/other/SLSBioSpecialty_Lab_Solution_Bio_Co._Ltd-logo.jpg){kind=logo}
